Chunyan Gu

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Top Venues

Cell death & disease

Signal transduction and targeted therapy

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Zhen Hua, Rongfang Wei, Mengjie Guo, Zigen Lin, Xichao Yu, Xinying Li, Chunyan Gu, Ye Yang
YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis. Oncogene 41 (10) (2022)
Ying Chen, Jinjun Qian, Pinggang Ding, Wang Wang, Xinying Li, Xiaozhu Tang, Chao Tang, Ye Yang, Chunyan Gu
Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation. Cell death & disease 13 (9) (2022)
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, Ye Yang
Alternative splicing and cancer: a systematic review. Signal transduction and targeted therapy 6 (1) (2021)
Xiaozhu Tang, Mengjie Guo, Pinggang Ding, Zhendong Deng, Mengying Ke, Yuxia Yuan, Yanyan Zhou, Zigen Lin, Muxi Li, Chunyan Gu, Xiaosong Gu, Ye Yang
BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. Signal transduction and targeted therapy 6 (1) (2021)
Renjie Dou, Jinjun Qian, Wei Wu, Yanxin Zhang, Yuxia Yuan, Mengjie Guo, Rongfang Wei, Shu Yang, Artur Jurczyszyn, Siegfried Janz, Meral Beksac, Chunyan Gu, Ye Yang
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma. Cell death & disease 12 (2) (2021)
Jianhao Hou, Jinjun Qian, Zhenlin Li, Aixiu Gong, Sixia Zhong, Li Qiao, Shihui Qian, Yanxin Zhang, Renjie Dou, Rui Li, Ye Yang, Chunyan Gu
Bioactive Compounds from Abelmoschus manihot L. Alleviate the Progression of Multiple Myeloma in Mouse Model and Improve Bone Marrow Microenvironment. OncoTargets and therapy 13 (2020)
Chunyan Gu, Ting Lu, Wang Wang, Miaomiao Shao, Rongfang Wei, Mengjie Guo, Rui Li, Li Qiao, Ye Hu, Fenghuang Zhan, Anja Seckinger, Dirk Hose, Ye Yang
RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma. Leukemia 35 (6) (2020)